Innoviva Future Growth
Future criteria checks 1/6
Innoviva is forecast to grow revenue at 6.4% per annum.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 21.6% |
Revenue growth rate | 6.4% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 07 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 378 | N/A | 140 | 123 | 2 |
12/31/2025 | 353 | N/A | 90 | 101 | 2 |
12/31/2024 | 354 | N/A | N/A | 71 | 2 |
9/30/2024 | 353 | 65 | 162 | 163 | N/A |
6/30/2024 | 330 | 145 | 158 | 158 | N/A |
3/31/2024 | 312 | 181 | 152 | 152 | N/A |
12/31/2023 | 310 | 180 | 141 | 141 | N/A |
9/30/2023 | 290 | 50 | 116 | 117 | N/A |
6/30/2023 | 290 | 233 | 88 | 88 | N/A |
3/31/2023 | 318 | 233 | 129 | 129 | N/A |
12/31/2022 | 331 | 214 | 202 | 202 | N/A |
9/30/2022 | 373 | 293 | 291 | 291 | N/A |
6/30/2022 | 404 | 99 | 372 | 372 | N/A |
3/31/2022 | 396 | 188 | 378 | 378 | N/A |
12/31/2021 | 392 | 266 | 364 | 364 | N/A |
9/30/2021 | 375 | 309 | 351 | 351 | N/A |
6/30/2021 | 365 | 265 | 329 | 329 | N/A |
3/31/2021 | 344 | 253 | 324 | 324 | N/A |
12/31/2020 | 337 | 224 | 313 | 313 | N/A |
9/30/2020 | 322 | 216 | 295 | 295 | N/A |
6/30/2020 | 299 | 228 | 278 | 278 | N/A |
3/31/2020 | 285 | 189 | 254 | 254 | N/A |
12/31/2019 | 261 | 157 | 257 | 257 | N/A |
9/30/2019 | 265 | 375 | 252 | 252 | N/A |
6/30/2019 | 261 | 382 | 255 | 255 | N/A |
3/31/2019 | 264 | 399 | 250 | 250 | N/A |
12/31/2018 | 261 | 395 | 224 | 224 | N/A |
9/30/2018 | 251 | 190 | 210 | 210 | N/A |
6/30/2018 | 238 | 166 | N/A | 193 | N/A |
3/31/2018 | 229 | 147 | N/A | 164 | N/A |
12/31/2017 | 217 | 134 | N/A | 142 | N/A |
9/30/2017 | 191 | 101 | N/A | 115 | N/A |
6/30/2017 | 176 | 92 | N/A | 92 | N/A |
3/31/2017 | 150 | 72 | N/A | 81 | N/A |
12/31/2016 | 134 | 60 | N/A | 61 | N/A |
9/30/2016 | 113 | 38 | N/A | 47 | N/A |
6/30/2016 | 93 | 19 | N/A | 29 | N/A |
3/31/2016 | 71 | -4 | N/A | 19 | N/A |
12/31/2015 | 54 | -19 | N/A | 10 | N/A |
9/30/2015 | 38 | -39 | N/A | -1 | N/A |
6/30/2015 | 26 | -56 | N/A | -25 | N/A |
3/31/2015 | 16 | -68 | N/A | -82 | N/A |
12/31/2014 | 8 | -74 | N/A | -131 | N/A |
9/30/2014 | 3 | -66 | N/A | -166 | N/A |
6/30/2014 | 2 | -55 | N/A | -186 | N/A |
3/31/2014 | 2 | -9 | N/A | -149 | N/A |
12/31/2013 | 5 | -31 | N/A | -130 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if HVE's forecast earnings growth is above the savings rate (1%).
Earnings vs Market: Insufficient data to determine if HVE's earnings are forecast to grow faster than the German market
High Growth Earnings: Insufficient data to determine if HVE's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: HVE's revenue (6.4% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: HVE's revenue (6.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if HVE's Return on Equity is forecast to be high in 3 years time